admin – Page 6942 – Get News Story

Ozan Ozerk Talks About Utilising AI in Fintech at Qatar Web Summit

Fintech entrepreneur Dr Ozan Ozerk joined the ‘Utilising AI in Fintech’ panel at the Qatar Web Summit 2024. During the session, Dr Ozerk and co-panellist Edward Achtner, Head of AI at HSBC, exchanged thoughts on how AI is likely to impact the way fintechs think and operate. The summit, a key event for business leaders worldwide, was held in Doha on February 26-29 and featured over 300 speakers and panellists.

Dr Ozan Ozerk, a globally renowned figure in fintech, is the founder of Openpayd (a banking-as-a-service provider based in the UK), European Merchant Bank (EMBank), and e-money institution Ozan Electronic Money (Ozan Elektronik Para), Turkiye’s innovative payment service provider for businesses.

In response to a question in the panel about the areas of fintech where AI can be most helpful, Dr. Ozan Ozerk pointed to customer onboarding, handling compliance and risk, and transaction monitoring. AI makes scalable growth achievable here, as opposed to a serious barrier for fintechs. Fintechs can meet the substantial workload demands of client acquisition by using AI, either through AI-powered service providers or internally, to speed up processing and reduce the risk of human or algorithmic errors.

Ozan Ozerk was confident, with a caveat, about how AI could be helpful with managing money better and more safely. He stated that “AI should and would successfully help guide us to the right financial products and improve trading decisions, decreasing the burden of individually processing a load of information along the way.”

Yet he alerted the audience to how inclusive the process would be. Financial institutions are regulated to have cutting-edge cybersecurity and effectively apply KYC/AML processes. However, AI usage could further erode service inclusivity if it were not handled delicately. Ozerk recognised the threat posed by criminal organisations or individuals that abuse AI but was also concerned about a widening gap in access, where “basically people might be left out just because a robot told you they should not be banking with you.”

Dr Ozan Ozerk noted that to deliver AI’s full benefits to customers, all the links in the chain must be connected in terms of institutions and their technology. In international payments, various parties rely on each other to move money or assets across borders and institutions. As AI is used increasingly, companies that do not utilise AI may become bottlenecks.

As for the expected changes in the workforce and talent pool that the extended use of AI would impose on fintechs, Dr Ozan Ozerk felt confident from a historical perspective that society would successfully adapt to them. He believes AI will be a big player for a lot of the manual work being delegated to technology. More employees will take on tasks governing and utilising AI, performing new professions, occupying new positions within each company, and performing new societal roles at large. AI may be especially useful to companies in countries with declining populations to help keep their competitive edge.

Ozan Ozerk explained the challenges of pioneering AI in financial services: AI is still in its early phase, industry regulation is not precise, and the technology is yet unproven in many aspects. Ozerk’s approach in their own organisation is not to “break things and move on” but to constantly review the AI practices in non-regulated sectors and selectively apply them to fintech.

Dr. Ozerk expressed his excitement about the future potential of AI and technology to level the playing field between big, long-established financial institutions and younger contenders in the eyes of retail clients. Five years on, he is curious to see how clients will choose financial services—if the ones with the best engines, robots, or algorithms will win them over. He expects the older and younger institutions to face off in an even more challenging way than today.

Media Contact
Company Name: OZAN Electronic Money Institution
Contact Person: Gizem Lalli
Email: Send Email
Country: Turkey
Website: https://www.ozan.com/

Leading Maker of Eco-Safety Gear Milerd Launches a Guide to EMF Meters & Air Quality Monitors

The premier manufacturer of modern eco-safety devices is offering 80+ proprietary models that make homes safer and greener. Due to high popular demand, the company’s experts have created a comprehensive guide to its ever-expanding catalog.

The leading manufacturer of technological gadgets for eco-friendly households, Milerd Technology LLC has been standing at the forefront of innovation for over a decade. Founded in 2010, the enterprise boasts over 20+ international patents and more than 80+ unique models crafted by its team of in-house experts.

As the need for reliable, high-quality ecological safety products soars, the organization saw it was necessary to educate consumers about the benefits of these essential appliances and how to properly use them. The firm is continuously uploading new showcase videos on its social media pages in a bid to keep its customers in the know about the latest eco-conscious inventions.

Unlike most of its peers, this green-friendly brand designs and produces all of its products in privately held facilities. The true advantage of purchasing eco-safety items from this enterprise lies in continuous improvements its production and R&D teams are making in both ecological and technological fields.

Food, air, and environment purifiers are just the tip of the iceberg that is the brand’s catalog.

The Personal Food Detoxification Device has been the main talking point among green-minded homeowners, as it is capable of eliminating toxins found in food at a molecular level. The critically acclaimed HiStand, a solar-powered smart Geiger counter is equally popular and deemed an essential piece of a modern apartment.

One of the brand’s most recent offerings is the sophisticated HiRange, which was almost instantly dubbed the “best EMF meter” by numerous satisfied customers. After months of research and development, the team finally launched this multi-field EMF meter striving to deliver a reliable, accurate product that can measure 5G, electric, and magnetic fields.

This groundbreaking invention is the first fully wearable EMF meter, bringing portable convenience and surgical precision to the table. As underscored by the organization’s spokesperson, a dynamic measuring range and compactness set the HiRange model apart from more traditional detectors.

This appliance has been purposefully made to be able to accurately recognize and track both low and high frequencies, spanning up to a whopping 8 GHz. Knowing that most families live surrounded by electrical equipment and gadgets, the effectiveness and ease of use is invaluable in making homes safer.

Beyond tracking frequencies around the clock, the product also boasts an internal storage system that compiles accumulated dose measurement history over the span of 30 days. Equipped with a streamlined user interface, accessing data is simple to the point that even children can efficiently use this item.

For consumers who do not know how to use such a gadget, detailed step-by-step instructions are included in every package. Moreover, the company offers a refund guarantee lasting 30 days after the purchase was made, as well as free shipping across the globe.

HiRange is a 4-in-1 option which, apart from measuring RF, magnetic, and electric signals, also analyzes accumulated doses of electromagnetic signals. This revolutionary device boasts a long battery life that can withstand up to a week of continuous usage and was purposefully crafted to be as user-friendly as possible.

The firm’s spokesperson said the design stems from a growing need for accurate, reliable and modern-looking tracking devices. The tracker’s versatility and simplified functions can be leveraged into pinpointing hotspots where electromagnetic radiation is commonplace, as well as quickly discover growing levels of electromagnetic fields presence both in and around the house.

In a world where electrical signals and radiation are commonplace, this invention is having a profound impact in the lives of people across all compass points. The company keeps pushing the boundaries in the industry of eco-safety merchandise and remains committed to consistently delivering the promise of quality and excellence.

More information is available on the official website.

Media Contact
Company Name: Milerd
Contact Person: Michael Lehmann
Email: Send Email
Country: United States
Website: https://milerd.com/

Caroline, The Painted Turtle: The Journey Begins by Jeanne McIntosh Rietzke Recognized as a Finalist in International Book Awards Contest

Jeanne McIntosh Rietzke’s Caroline, The Painted Turtle: The Journey Begins is recognized for its outstanding writing, design and overall market appeal out of thousands of books submitted into the Book Excellence Awards.

Jeanne McIntosh Rietzke is the multiple award-winning author and illustrator of Caroline, The Painted Turtle: The Journey Begins and Caroline, The Painted Turtle: Life in Key West, a series of empowering children’s picture books that promote diversity, inclusion, self-awareness and friendship.

Originally from Charleston, SC, Jeanne graduated from The University of South Carolina, Columbia, with a degree in Fine Art. Since 1992, she has been a professional watercolor artist and her colorful, coastal and marine themed paintings have sold nationally and internationally. Her work has also won numerous awards, been accepted into dozens of juried shows, and featured in national and international publications.

Jeanne now makes her home in Wilmington, NC, with her husband Jacques and their six cats.

This one-on-one interview shares Jeanne’s background and experience in writing the first book in the series, Caroline, The Painted Turtle: The Journey Begins.

Tell us about Caroline, The Painted Turtle: The Journey Begins.

Caroline, The Painted Turtle: The Journey Begins follows Caroline, a baby green sea turtle, as she begins her life’s journey. Her adventures lead her from Carolina Beach, North Carolina to Key West, Florida. Along the way, she meets many colorful creatures who share important life lessons. From Banban, the wise blue fish, who tells Caroline to stay curious, be patient and ask questions; to Geeter, a young eel who shows her how to camouflage with her surroundings; to Solomon, a smart octopus who tells her that the lessons she learns from other sea creatures is what changes her for the better; to Jimmy, the kind manatee who explains that anger is a waste and to let your differences keep educating you—the book is designed to teach children to accept that everyone is different, and that being different is not only okay, but absolutely wonderful!

As Caroline learns from each creature, her shell starts to change color, with every new color symbolizing new knowledge. In these turbulent times, the recurring theme of staying curious, trusting your instincts, and appreciating our differences is a message that both young readers and adults can benefit from.

What inspired you to write Caroline, The Painted Turtle: The Journey Begins?

Caroline, The Painted Turtle: The Journey Begins was inspired by recent global events and my overall concern for how adults are acting worldwide. As it turned out, my publication date was the day that Russia invaded Ukraine.

Humans are forgetting that our differences are what make us such an incredible species, so I’m hoping that through Caroline, the next generation will have more kindness and compassion for one another.

How did you feel when you found out you received a Book Excellence Award?

I was thrilled! As my first book, this was wonderful validation of the book’s high quality and I am looking forward to the sales and exposure the award will bring.

How did your background and experience influence your writing?

I believe being creative is a wide band of energy that can lead a human to express an unseen vision. Your art should be your truth, no matter what that is for you.

As a fine artist by trade, I have been painting marine life for over 30 years. My subject matter may be anything in nature, but sea turtles have always been my passion and a main theme of my art.

When a friend mentioned that I should illustrate children’s books, I decided to write my own story too. Both of my parents were writers and I have always been an avid reader.

It took some work, but I am proud and grateful for what I have created and the positive impact my work is having on readers around the world.

What is one message you would like readers to remember?

Just because someone looks different, feels different or speaks differently, that doesn’t make them wrong. They’re just different!

Traveling can help open your eyes to why we’re different, and teach you new things about yourself and others.

In the end, our differences should be shared and celebrated.

Purchasing the Book

Caroline, The Painted Turtle: The Journey Begins has received positive reviews from well-known literary organizations, authors, and reviewers around the world. Book Excellence writes, “A charming story full of color, delightful sea creatures, and wisdom through the ages.” In addition, reviewer Jodi Bunting writes, “A great story, with wonderful life lessons on adventure, curiosity, acceptance & growth…basically, how we all learn from each other and how it molds us personally…the artwork and colors were amazing!”

The book is available for sale on Amazon, Barnes & Noble, Etsy, Books-a-Million, Walmart and other online bookstores. Readers are encouraged to purchase their copy today: https://www.amazon.com/Caroline-Painted-Turtle-Journey-Begins/dp/1838754881/

Readers, parents, educators and book clubs are encouraged to visit Jeanne’s website to purchase a copy of the book and receive updates on author visits and new book releases: https://carolinethepaintedturtle.com. You can also find Jeanne on Facebook and Instagram.

Media Contact
Company Name: Author News Network
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: authornewsnetwork.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Caroline, The Painted Turtle: The Journey Begins by Jeanne McIntosh Rietzke Recognized as a Finalist in International Book Awards Contest

Revolutionizing Skincare: Top Dermatologist in Corpus Christi Introduces Groundbreaking Treatment

CORPUS CHRISTI, Texas – April 4, 2024 – A leading dermatologist in Corpus Christi, with over two decades of experience and numerous accolades in dermatology, has today unveiled an innovative approach to skincare that promises to transform the way we treat our skin. Renowned for their expertise and pioneering treatments, this top dermatologist is set to change the skincare game with their revolutionary approach.

The new method diverges sharply from traditional skincare routines by integrating the latest in skin health technology and holistic practices. This unique combination not only targets surface-level symptoms but also addresses the root causes of skin concerns, offering a comprehensive and enduring solution to patients. The dermatologist Corpus Christi community is abuzz with anticipation for this state-of-the-art treatment.

Dermatologist Corpus Christi

Backed by rigorous scientific research, this advanced skincare approach has been proven to significantly improve skin health and appearance. Clinical studies and patient trials highlight notable improvements in skin texture, elasticity, and overall complexion, showcasing the effectiveness of this innovative methodology.

Patients who have experienced this cutting-edge treatment are sharing their success stories, emphasizing dramatic before-and-after results. Testimonials reveal not only physical transformations but also enhanced confidence and wellbeing, further underscoring the impactful nature of the treatment.

Exclusively available at the Corpus Christi clinic, patients now have the unprecedented opportunity to access this advanced skincare solution. This revolutionary approach is poised to set a new standard in skin care excellence, offering hope and remarkable results to those seeking the best in skin health.

The excitement surrounding this revolutionary skincare treatment extends beyond the clinic’s walls, promising to influence the broader field of dermatology profoundly. As more individuals experience the remarkable benefits of this approach, the Corpus Christi clinic is preparing for an influx of patients locally and from surrounding regions. The dermatologist’s innovative technique, blending cutting-edge technology with holistic practices, sets a precedent that could redefine standards in skincare treatments globally. This holistic perspective not only exemplifies a shift towards more inclusive and comprehensive skin health strategies but also emphasizes the importance of treating the individual as a whole. With this groundbreaking treatment now available, the quest for healthier, more resilient skin is more attainable than ever, marking a significant milestone in dermatological care.

For more information or to schedule an appointment, interested individuals are encouraged to contact the clinic directly. The team is ready to provide further details and assist patients in their journey towards radiant, healthy skin.

In conclusion, the introduction of this revolutionary skincare approach by a top dermatologist in Corpus Christi heralds a new era in dermatological care. Offering unmatched benefits and backed by solid science, it stands as a beacon of hope for individuals striving for optimal skin health. The future of skincare looks bright, with innovative treatments like this leading the way.

Visit Our website – www.dermatologist-corpus-christi.com

Media Contact

Tia Dhawan

Dermatologist Corpus Christi

123 Main Street, Corpus Christi, TX 78401

(325) 4809516

Home

Media Contact
Company Name: Dermatologist Corpus Christi
Contact Person: Tia Dhawan
Email: Send Email
Phone: (325) 4809516
Address:123 Main Street
City: Corpus Christi
State: Texas
Country: United States
Website: https://dermatologist-corpus-christi.com/

DiscountedLabs.com Celebrates National Public Health Week with Special Offers on Lab Testing

Affordable Lab Tests- No Doctor Visit- Labs Near You

April 4, 2024 – In recognition of National Public Health Week, observed annually during the first full week of April, DiscountedLabs.com announces a special promotion on its comprehensive range of blood tests for both men and women. This initiative underscores the company’s commitment to making health monitoring accessible and affordable, and encourages individuals to take proactive steps towards managing their health.

National Public Health Week, a time to reflect on the importance of preventive care and wellness, serves as an ideal backdrop for DiscountedLabs.com’s mission. The company offers a wide array of tests, including those for hormone levels, nutritional deficiencies, organ function, and more, without the need for a doctor’s visit. This initiative aligns perfectly with this year’s theme of “Building Bridges to Better Health,” making it easier for people to understand and take control of their health indicators.

Nelson Vergel, DiscountedLabs.com’s CEO states, “We are proud to support National Public Health Week by providing an opportunity for individuals to access affordable and convenient lab testing. Our goal is to bridge the gap between needing and having essential health information. This week-long promotion is just one way we’re contributing to a healthier community.”

During National Public Health Week, DiscountedLabs.com offers additional discounts on their already affordable prices, making it even more accessible for individuals to monitor key health indicators. This initiative is not only an opportunity for savings but also a chance to increase awareness about the value of regular health screenings.

Customers can take advantage of this offer by visiting the DiscountedLabs.com website, where they can choose from a variety of tests, order online, and then visit one of the numerous partner labs across several U.S. states for sample collection. The process is designed for convenience and confidentiality, with fast and secure online results.

For more information about the National Public Health Week promotion and to view the available tests, visit DiscountedLabs.com.

Media Contact
Company Name: Discounted Labs
Contact Person: Nelson Vergel
Email: Send Email
Country: United States
Website: https://www.discountedlabs.com/

Electric Gates Newry now offering 3 Year Guarantee on all new Electric Gate Installations

With over 23 years of experience in the industry, AutoGate Northern Ireland has built a reputation for excellence in electric gate installation and service. Our team of skilled professionals is dedicated to providing top-quality solutions tailored to meet the unique needs of each customer.

Electric Gates Newry, a local trade name of AutoGate Northern Ireland, is proud to announce a new offering aimed at providing even greater peace of mind to our valued customers. Starting immediately, all new electric gate installations in Newry and the surrounding areas will come with a comprehensive 3-year guarantee.

At AutoGate Northern Ireland, we understand the importance of trust and reliability when it comes to securing your property with electric gates. That’s why we’re delighted to introduce this extended guarantee period, demonstrating our confidence in the quality of our products and workmanship.

This new 3-year guarantee reaffirms our commitment to delivering superior service and ensuring the long-term satisfaction of our customers. Whether you’re considering swing gates, sliding gates, or any other type of electric gate, you can trust Electric Gates Newry to provide reliable, secure, and durable solutions for your property.

Adrian McGivern, the owner of AutoGate, has over 23 years experience working with electric gate repairs and gate automation installations. “We will repair all types of electric gate systems, even those we did not install. Several electric gate business owners in the area have now retired and we are happy to support their former customers when they are in need of assistance with their gate automation systems.”

Patterson Gates from Kilkeel and Electric Gate Systems from Newry have retired from the trade. Their customers can contact Adrian on 07855-781433 when they are in need of service or electric gate repairs.

Experience the peace of mind that comes with our new 3-year guarantee on all new electric gate installations. Contact Electric Gates Newry today to discuss your requirements and schedule a consultation. You can reach us at 07855-781433 or visit our website at https://northern-ironwork.com/

About AutoGate Northern Ireland:

AutoGate Northern Ireland is a leading provider of electric gate installation and service, serving customers in Belfast, Newry, and across Northern Ireland for over two decades. With a focus on quality, reliability, and customer satisfaction, we strive to exceed expectations with every project we undertake.

Media Contact
Company Name: AutoGate NI
Contact Person: Adrian McGivern
Email: Send Email
Phone: 07855781433
Address:127 Silverbridge Road Mullaghbawn
City: Newry
State: Down
Country: United Kingdom
Website: https://northern-ironwork.com

Dr. Brian “BK” Kent selected as Top Strategic Advisor of the Year by IAOTP

Dr. Brian “BK’ Kent, Strategic Advisor, was recently selected as Top Strategic Advisor of the Year for 2024 by the International Association of Top Professionals (IAOTP) for his outstanding leadership, dedication, and commitment to the industry.

Inclusion with the International Association of Top Professionals is an honor in itself; only a few members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, longevity in the field, other affiliations, and contributions to their communities. All Honorees are invited to attend the IAOTP annual award gala at the end of this year for a night to honor their achievements.

www.iaotp.com/award-gala

With close to four decades of experience, Dr. Brian Kent is a global leader and senior consultant focusing on International and Domestic Operations. Over the past 3 decades he has worked in multiple levels of leadership with several government agencies to build partner capacity and provide strategy for integration across the Department of Defense and Department of State. This work in emerging technologies focuses in the areas of ISR, Data, and Logistics.

As a Strategic Advisor and Consultant, he advises business areas in Technology Transfer/Transition, Real Estate, Finance and Investing. Having served in academic roles as a Principal Investigator, Business and Finance Professor and Executive Director for the Center for Defense and Homeland Security (CDHS), Dr. Kent provides an expertise and appetite for growth. Through his engagement with emerging technologies, he has supported DARPA and the DoD Acquisition/Defense Contracting Industry. He builds on structure, scaling, and leaning processes.

As a serial entrepreneur, Dr. Kent’s first business endeavor was a Real Estate Investing Company. The company grew through renovations, new construction and eventually became licensed as a General Contractor. The market included single family, multi-family and commercial properties in North Carolina, South Carolina, and Florida. Dr. Kent provides a wealth of knowledge across the business market and has founded and led companies in the Defense Industry and Medical Arena. He continues to build and advise companies for strategic growth through innovation.

As an accredited investor, Dr. Kent has also pursued endeavors to invest in and build technology companies. These have included startups in medical, real estate, aviation, electronics, and biometrics. He continues his support in the arena on the commercial market through Angel Funds, Venture Capital, and Consulting.

Prior to his career, Dr. Kent earned his Master’s Degree in Management Technology from Murray State University and completed his PhD in Business at Trident University with a dissertation on Technology Acceptance.

Throughout his illustrious career, Brian has received many awards and accolades and has been recognized worldwide for his accomplishments. In 2011 and 2012, he was awarded Fastest Growing Business by INC Magazine. He was Entrepreneur of the Year by Methodist University in 2015. In 2023 He was awarded Top 10 Inspiring Leaders of 2023 by Industry Era Magazine. He was just awarded World’s Top-Performing Business Personalities Making an Impact in 2024. This year, he will be considered for a feature in TIP (Top Industry Professionals) Magazine. He will be honored at IAOTP’s annual awards gala at Gaylord Opryland Resort in Nashville this December for his selection as Top Strategic Advisor.

In addition to his successful career, he is a Philanthropist. Dr. Kent continues to give back. He is the co-founder for the Kent Family Foundation and E2E Alliance Foundation. He provides scholarships for underprivileged children from depressed areas or disadvantaged children placed in children’s homes or the state systems. Additionally, as a Veteran, he supports veteran, and first responder causes across the nation.

The President of the International Association of Top Professionals (IAOTP), Stephanie Cirami, stated: “Choosing Dr. Kent for this honor was an easy decision for our panel to make. He is inspirational, influential, and a true visionary and thought leader. We cannot wait to meet him and celebrate his accomplishments at this year’s gala.”

Looking back, Dr. Kent attributes his success to his perseverance, work ethic, and mentors he had along the way. When not working, he enjoys spending time with his family. In the future, he hopes to inspire and influence those getting into the field.

For more information please visit: https://www.brianlkent.com/

About IAOTP

The International Association of Top Professionals (IAOTP) is an international boutique networking organization that handpicks the world’s finest, most prestigious top professionals from different industries. These top professionals are given an opportunity to collaborate, share their ideas, be keynote speakers, and to help influence others in their fields. This organization is not a membership that anyone can join. You have to be asked by the President or be nominated by a distinguished honorary member after a brief interview.

IAOTP’s experts have given thousands of top prestigious professionals around the world, the recognition and credibility that they deserve and have helped in building their branding empires. IAOTP prides itself to be a one-of-a-kind boutique networking organization that hand picks only the best of the best and creates a networking platform that connects and brings these top professionals to one place.

For More information on IAOTP please visit: www.iaotp.com

Media Contact
Company Name: IAOTP
Contact Person: Media Relations
Email: Send Email
Phone: (212) 634-4427
Country: United States
Website: https://www.mediacontacts.co

Nancy Lynne Harris Inducted into IAOTP’s Hall of Fame

Nancy Lynne Harris is a Shaman, Spiritual Teacher & Author of GodSpirits United LLC. She will be inducted into the exclusive Hall of Fame by the International Association of Top Professionals (IAOTP). Her expertise and extraordinary talents have afforded her this merit.

Inclusion with the International Association of Top Professionals is an honor; only 10 IAOTP members are inducted into the exclusive Hall of Fame. These special honorees are distinguished based on their longevity in their fields, the contributions they have made to society, and the impact they have had on their industries. Ms Harris will be inducted into the exclusive Hall of Fame at IAOTP’s 2024 Annual Awards Gala at Nashville’s magnificent Opryland Hotel this December.

www.iaotp.com/award-gala

With over 25 years of professional experience as a Spiritual Teacher and Shaman, Nancy has certainly proven herself to be an accomplished professional and expert in her field. She is a dynamic, results-driven leader specializing in spiritual counseling and shamanic treatments. Nancy is widely known for her ability to heal depression and glaucoma.

She is the Founder of GodSpirits United, LLC, a company dedicated to assisting individuals in overcoming medically incurable illnesses and addictions through the transformative power of energy healing. Nancy provides energy treatments and spiritual readings, both in person and remotely via telephone. She also offers online training called “12 Steps to Heal Yourself Without Medicine.”

Nancy’s profound comprehension of Jesus’ energy dynamics propelled her to the pinnacle of her professional journey. She managed to recover on her own after her left femur (leg bone) became detached from her hip bone following the tragic loss of her oldest son, Jeff. After enduring months of excruciating pain, she managed to find healing by recognizing the emotional distance she had with her son and how it was affecting her physical well-being. Through the power of her unwavering belief in the unbreakable bond with God, she experienced a remarkable transformation as her sense of isolation dissolved and her physical well-being swiftly improved. Nancy successfully cured her son Michael of congenital glaucoma, a condition that is considered medically incurable. Despite the doctors performing two eye surgeries to prevent further damage to his optic nerve caused by high pressure, Nancy’s intervention proved to be the turning point in preventing blindness.

Before embarking on her career path, Nancy graduated from The Four Winds Society, the world’s most extensive professional training in Andean energy healing and shamanism. She completed advanced training in Theta Healing and received training in spiritual healing through the Eschatology Foundation in Los Angeles, CA. Nancy has worked with mentors such as Dr. Alberto Villoldo, Don Oscar Miro-Quesada, James VanPraagh, and Dr. Hank Wesselman. In addition to her spiritual achievements, Nancy holds a Master of Arts Degree in Music Theory and a Bachelor of Arts Degree in Piano Performance. She is Nationally Certified as a piano teacher through Music Teachers National Association.

Throughout her illustrious career, Nancy has received awards and accolades and is recognized worldwide for her notable leadership and dedication to the profession. In 2021, Ms Harris was awarded the IAOTP’s Empowered Woman of the Year Award. In 2020, she received IAOTP’s Top Shaman & Spiritual Teacher of the Year. Nancy was featured in TIP (Top Industry Professional) Magazine and is being considered for the prestigious Lifetime Achievement Award given by IAOTP. She will be inducted into IAOTP’s prestigious Hall of Fame this December at IAOTP’s Annual Awards Gala at the magnificent Opryland Hotel. In past years, Nancy received an award from Worldwide Who’s Who for excellence in energy medicine.

Nancy is not only accomplished in her career, but she is also highly regarded as a speaker who guides individuals in harnessing their creative energy to transform their blood chemistry and achieve healing. She also offers educational workshops emphasizing the power of positive thinking to promote the flow of healthy fluids throughout the body, regulating body chemistry and facilitating healing.

Nancy, a published author through Amazon.com, has written numerous books on these subjects. She has a collection of publications, one of which is Miracles Master the Art: Healing Medically Incurable Illness; Mental Illness Heal Yourself; Invasion Revealed: Healing Alcoholism, Mental Illness & Drug Addiction; Heal Yourself of Anything: Example Glaucoma; COMI: A Guide to Consciously Overcoming Mental Illness and Healing Hang-Ups: Depression, Alcohol, and Drug Addiction.

Looking back, Nancy attributes her success to her training, insightfulness, and unique ability to teach others how to heal themselves without medicine. When not working, Nancy enjoys playing jazz piano. For the future, she hopes to continue helping people stay healthy and free of pain while freeing the body and aura from negative emotional energy.

For more information on Nancy Lynne Harris, please visit: www.nancylynneharris.com

Her books can also be seen and ordered from this link:

https://vendor.getstartedbooks.com/product-tag/nancy-lynne-harris/

To view her video Biography, please visit: https://youtu.be/ZpMF5CHCqfs

About IAOTP

The International Association of Top Professionals (IAOTP) is an international boutique networking organization that handpicks the world’s finest, most prestigious top professionals from different industries. These top professionals are given an opportunity to collaborate, share their ideas, be keynote speakers, and help influence others in their fields. This organization is not a membership that anyone can join. You have to be asked by the President or be nominated by a distinguished honorary member after a brief interview.

IAOTP’s experts have given thousands of top prestigious professionals around the world, the recognition and credibility that they deserve and have helped in building their branding empires. IAOTP prides itself to be a one of a kind boutique networking organization that hand picks only the best of the best and creates a networking platform that connects and brings these top professionals to one place.

For more information on IAOTP please visit: www.iaotp.com

Media Contact
Company Name: IAOTP
Contact Person: Media Relations
Email: Send Email
Phone: (212) 634-4427
Country: United States
Website: https://www.mediacontacts.co

Swoop launches voice offering for SMEs

ASX-listed telco Swoop has launched a new voice offering aimed at small to medium-sized businesses (SMBs).

Launched this year, the offering includes unlimited SIP trunks and unified communications voice services.

The launch follows Swoop’s acquisition of Sydney-based telecommunications wholesale voice service Seventeen Services.

“This acquisition is set to propel Swoop to new heights by enabling the launch of cutting-edge voice products, amplifying the company’s offerings, and cementing its position as a frontrunner in the rapidly evolving world of business communication,” Swoop’s founder and CEO Alex West said.

“The union of these two companies signifies the dawn of a thrilling journey, one that promises to reshape the way businesses communicate and interact in the digital age.”

Swoop has also partnered with NBN Co to deliver Fibre to the Premise (FTTP) in more than 250,000 businesses.

This comes after the introduction of three scalable business NBN plans for SMEs, with a residential bundle incorporating a multi-technology mix, the Business Bundle using FTTP and the Enterprise Bundle using enterprise ethernet.

“As we continue to expand rapidly with the ambition of becoming Australia’s premier challenger in the telecommunications market, with these new voice and NBN bundles we are offering unique telco and internet bundles as a more cost effective alternative to traditional big telecommunication services,” Swoops head of voice James Dover said.

“We’re excited about this next chapter of our ongoing evolution as a core and essential provider to small and medium sized businesses throughout Australia.”

About Swoop

Swoop is a national provider of data and voice services to wholesale, business and residential customers with a focus on its own fibre and fixed wireless infrastructure. The Swoop network is designed and scaled to deliver ultra-reliable, high throughput, flexible telecom network services. Swoop is established and has the goal to build its business to become Australia’s best challenger internet and telecommunications provider.

Media Contact
Company Name: Swoop Holdings Limited
Contact Person: David Michaels, Chief Revenue Officer
Email: Send Email
Phone: 0438 441 594
Address:Level 5, 126-130 Phillip Street
City: Sydney
State: NSW
Country: Australia
Website: www.swoop.com.au

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Swoop launches voice offering for SMEs

Pancreatic Ductal Adenocarcinoma Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Taiho Pharma, Genmab, Bristol-Myers

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pancreatic Ductal Adenocarcinoma pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic Ductal Adenocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Pancreatic Ductal Adenocarcinoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

“Pancreatic Ductal Adenocarcinoma Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pancreatic Ductal Adenocarcinoma Market.

Some of the key takeaways from the Pancreatic Ductal Adenocarcinoma Pipeline Report:

Companies across the globe are diligently working toward developing novel Pancreatic Ductal Adenocarcinoma treatment therapies with a considerable amount of success over the years.
Pancreatic Ductal Adenocarcinoma companies working in the treatment market are Deciphera Pharmaceuticals, Revolution Medicines, Syntrix Biosystems, Amplia Therapeutics, ZielBio, Cend Therapeutics Inc, Cardiff Oncology, Eucure Biopharma, Jiangsu Alphamab Biopharmaceuticals, and others, are developing therapies for the Pancreatic Ductal Adenocarcinoma treatment

Emerging Pancreatic Ductal Adenocarcinoma therapies in the different phases of clinical trials are- DCC-3116, RMC-6236, SX-682, AMP 945, ZB131, CEND-1, Onvansertib, YH003, KN046, and others are expected to have a significant impact on the Pancreatic Ductal Adenocarcinoma market in the coming years.
In November 2023, CG Pharmaceuticals has initiated a Phase II clinical trial of ivaltinostat, utilizing the recommended Phase II dose (RP2D), for addressing metastatic pancreatic ductal adenocarcinoma (PDAC).
In January 2022, Jiangsu Alphamab Biopharmaceuticals initiated a multicenter, randomized, double-blind Phase III study in first-line Advanced Pancreatic Ductal Adenocarcinoma subjects (ENREACH-PDAC-01) to compare the efficacy and safety of KN046 combined with Gemcitabine and Nab-Paclitaxel versus placebo combined with Gemcitabine and Nab-Paclitaxel.
In July 2022, Cend Therapeutics, Inc. reported that data from the Phase 1b study of CEND-1, Cend’s lead investigational drug, in combination with gemcitabine and nab-paclitaxel for the treatment of first-line, metastatic pancreatic ductal adenocarcinoma (“mPDAC”) were published in The Lancet Gastroenterology and Hepatology.
In July 2022, I-Mab reported that a Phase 1 international multi-center clinical trial (IMCT) for patients with solid tumors, such as gastric cancer, gastroesophageal junction carcinoma, esophageal adenocarcinoma, and pancreatic ductal carcinoma, has treated the first patient in China with TJ-CD4B (also known as ABL111), a novel Claudin 18.2 x 4-1BB bispecific antibody.
In June 2022, The mRNA-based personalized neoantigen-specific immunotherapy (iNeST) autogene cevumeran (also known as BNT122, RO7198457) in combination with the anti-PD-L1 immune checkpoint inhibitor atezolizumab and chemotherapy in patients with resected pancreatic ductal adenocarcinoma (PDAC) was recently evaluated for safety and tolerability in a first-in-human Phase 1 study. It was confirmed that the method of tumor profiling for tailored vaccine creation and on-demand production of iNeST in a clinically appropriate period is feasible. The early findings revealed a good safety profile and heartening hints of clinical activity.
In June 2022, In order to advance Motixafortide through a randomized Phase 2b clinical trial in pancreatic ductal adenocarcinoma, or PDAC, BioLineRx Ltd. stated that the firm had entered into a collaboration agreement with GenFleet Therapeutics, an immuno-oncology-focused biopharmaceutical firm with headquarters in China.
In May 2022, Elicio Therapeutics announced that it had signed a clinical supply agreement with Regeneron to test the safety and effectiveness of using Regeneron’s Libtayo® (cemiplimab), a fully human monoclonal antibody that targets the immune checkpoint receptor PD-1 on T cells, in combination with Elicio’s lead asset, ELI-002, an investigational KRAS-targeted cancer vaccine, in patients with KRAS-driven tumors. Stage III and Stage IV non-small cell lung cancer (NSCLC), Stage IV colorectal cancer (CRC), and unresectable, locally progressed, or oligometastatic pancreatic ductal adenocarcinoma (PDAC) are among the KRAS-driven malignancies that will be examined with the combo therapy
In May 2022, The Phase 2 phase of Purple Biotech Ltd.’s ongoing investigation of CM24, a first-in-class monoclonal antibody with the potential to treat various malignancies, has begun. The objective of the open-label, multicenter Phase 2 research is to assess the safety and tolerability of CM24 in combination with the PD-1 inhibitor Opdivo® (nivolumab) and chemotherapy in patients with metastatic pancreatic adenocarcinoma (PDAC). Evaluating preliminary efficacy in PDAC treated as a second line is the study’s main goal.
In March 2022, The company’s flagship asset, mitazalimab, is being tested in the ongoing OPTIMIZE-1 clinical Phase Ib/II trial for the treatment of first-line metastatic pancreatic cancer. Phase Ib of the research has been successfully finished with the safety assessment of the second dose-escalation cohort (900 g/kg of mitazalimab in conjunction with mFOLFIRINOX) being completed. The 900 g/kg mitazalimab dose had been deemed safe by the Data Review Committee, and it was suggested that the Phase II study should proceed with the current dosing level. Phase II enrollment has started and is still going on at locations in Europe. Patients with metastatic pancreatic ductal adenocarcinoma are being evaluated for the safety and effectiveness of mitazalimab in OPTIMIZE-1, an open-label, multi-center Phase Ib/II research.

Pancreatic Ductal Adenocarcinoma Overview

Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that originates in the cells lining the pancreatic ducts, which are the tubes that carry digestive enzymes from the pancreas to the small intestine. PDAC is the most common type of pancreatic cancer, accounting for about 85% of cases. It is often diagnosed at an advanced stage and has a poor prognosis.

Get a Free Sample PDF Report to know more about Pancreatic Ductal Adenocarcinoma Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/pancreatic-ductal-adenocarcinoma-pipeline-insight

Emerging Pancreatic Ductal Adenocarcinoma Drugs Under Different Phases of Clinical Development Include:

DCC-3116: Deciphera Pharmaceuticals
RMC-6236: Revolution Medicines
SX-682: Syntrix Biosystems
AMP 945: Amplia Therapeutics
ZB131: ZielBio
CEND-1: Cend Therapeutics Inc
Onvansertib: Cardiff Oncology
YH003: Eucure Biopharma
KN046: Jiangsu Alphamab Biopharmaceuticals

Pancreatic Ductal Adenocarcinoma Route of Administration

Pancreatic Ductal Adenocarcinoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Intravenous
Subcutaneous

Pancreatic Ductal Adenocarcinoma Molecule Type

Pancreatic Ductal Adenocarcinoma Products have been categorized under various Molecule types, such as

Small molecule
Cell Therapy
Peptides
Polymer
Small molecule
Gene therapy

Pancreatic Ductal Adenocarcinoma Pipeline Therapeutics Assessment

Pancreatic Ductal Adenocarcinoma Assessment by Product Type
Pancreatic Ductal Adenocarcinoma By Stage and Product Type
Pancreatic Ductal Adenocarcinoma Assessment by Route of Administration
Pancreatic Ductal Adenocarcinoma By Stage and Route of Administration
Pancreatic Ductal Adenocarcinoma Assessment by Molecule Type
Pancreatic Ductal Adenocarcinoma by Stage and Molecule Type

DelveInsight’s Pancreatic Ductal Adenocarcinoma Report covers around 80+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Pancreatic Ductal Adenocarcinoma product details are provided in the report. Download the Pancreatic Ductal Adenocarcinoma pipeline report to learn more about the emerging Pancreatic Ductal Adenocarcinoma therapies

Some of the key companies in the Pancreatic Ductal Adenocarcinoma Therapeutics Market include:

Key companies developing therapies for Pancreatic Ductal Adenocarcinoma are – Elicio Therapeutics, Cend Therapeutics, Silenseed Ltd, Amplia Therapeutics Limited, Bristol-Myers Squibb, Revolution Medicines, Inc., Taiho Pharmaceutical, Genmab, Deciphera Pharmaceuticals LLC, NGM Biopharmaceuticals, Multitude Therapeutics, Seagen Inc., Alligator Bioscience, Cardiff Oncology, Novartis, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, Cantargia AB, Nelum Corp, GC Cell Corporation, OSE Immunotherapeutics, Eucure (Beijing) Biopharma Co., Ltd, Panbela Therapeutics, Inc., Onconic Therapeutics Inc., Tarveda Therapeutics, I-Mab Biopharma Co. Ltd., Incyte Corporation, ZielBio, Inc., DrugCendR Inc., Bayer, TriSalus Life Sciences, Jacobio Pharma, BioLineRx Ltd., Purple Biotech Ltd., Biomea Fusion, Inc., Phanes Therapeutics, Qualigen Therapeutics, and others.

Pancreatic Ductal Adenocarcinoma Pipeline Analysis:

The Pancreatic Ductal Adenocarcinoma pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Pancreatic Ductal Adenocarcinoma with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Pancreatic Ductal Adenocarcinoma Treatment.
Pancreatic Ductal Adenocarcinoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Pancreatic Ductal Adenocarcinoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Pancreatic Ductal Adenocarcinoma market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Pancreatic Ductal Adenocarcinoma drugs and therapies

Pancreatic Ductal Adenocarcinoma Pipeline Market Drivers

Increasing pervasiveness of the disease, increasing demand of targeted therapy are some of the important factors that are fueling the Pancreatic Ductal Adenocarcinoma Market.

Pancreatic Ductal Adenocarcinoma Pipeline Market Barriers

However, lack of early diagnostic markers, complicated and multifactorial nature of disease, diverse genetics and rapid metastasis and other factors are creating obstacles in the Pancreatic Ductal Adenocarcinoma Market growth.

Scope of Pancreatic Ductal Adenocarcinoma Pipeline Drug Insight

Coverage: Global
Key Pancreatic Ductal Adenocarcinoma Companies: Deciphera Pharmaceuticals, Revolution Medicines, Syntrix Biosystems, Amplia Therapeutics, ZielBio, Cend Therapeutics Inc, Cardiff Oncology, Eucure Biopharma, Jiangsu Alphamab Biopharmaceuticals, and others
Key Pancreatic Ductal Adenocarcinoma Therapies: DCC-3116, RMC-6236, SX-682, AMP 945, ZB131, CEND-1, Onvansertib, YH003, KN046, and others
Pancreatic Ductal Adenocarcinoma Therapeutic Assessment: Pancreatic Ductal Adenocarcinoma current marketed and Pancreatic Ductal Adenocarcinoma emerging therapies
Pancreatic Ductal Adenocarcinoma Market Dynamics: Pancreatic Ductal Adenocarcinoma market drivers and Pancreatic Ductal Adenocarcinoma market barriers

Request for Sample PDF Report for Pancreatic Ductal Adenocarcinoma Pipeline Assessment and clinical trials

Table of Contents

1. Pancreatic Ductal Adenocarcinoma Report Introduction

2. Pancreatic Ductal Adenocarcinoma Executive Summary

3. Pancreatic Ductal Adenocarcinoma Overview

4. Pancreatic Ductal Adenocarcinoma- Analytical Perspective In-depth Commercial Assessment

5. Pancreatic Ductal Adenocarcinoma Pipeline Therapeutics

6. Pancreatic Ductal Adenocarcinoma Late Stage Products (Phase II/III)

7. Pancreatic Ductal Adenocarcinoma Mid Stage Products (Phase II)

8. Pancreatic Ductal Adenocarcinoma Early Stage Products (Phase I)

9. Pancreatic Ductal Adenocarcinoma Preclinical Stage Products

10. Pancreatic Ductal Adenocarcinoma Therapeutics Assessment

11. Pancreatic Ductal Adenocarcinoma Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Pancreatic Ductal Adenocarcinoma Key Companies

14. Pancreatic Ductal Adenocarcinoma Key Products

15. Pancreatic Ductal Adenocarcinoma Unmet Needs

16 . Pancreatic Ductal Adenocarcinoma Market Drivers and Barriers

17. Pancreatic Ductal Adenocarcinoma Future Perspectives and Conclusion

18. Pancreatic Ductal Adenocarcinoma Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pancreatic Ductal Adenocarcinoma Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Taiho Pharma, Genmab, Bristol-Myers